Literature DB >> 20105079

Progress and pitfalls in defining the influence of highly active antiretroviral therapy on human papillomavirus-associated cervical disease.

Patti E Gravitt1, Gregory D Kirk.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20105079      PMCID： PMC2849627          DOI： 10.1086/650468

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  17 in total

1.  Role of highly active antiretroviral therapy in human papillomavirus-induced genital dysplasia in HIV-1-infected patients.

Authors:  G Orlando; M M Fasolo; M Schiavini; R Signori; A Cargnel
Journal:  AIDS       Date:  1999-02-25       Impact factor: 4.177

2.  Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys.

Authors:  N Breen; D K Wagener; M L Brown; W W Davis; R Ballard-Barbash
Journal:  J Natl Cancer Inst       Date:  2001-11-21       Impact factor: 13.506

3.  Cervical cancer screening among women in metropolitan areas of the United States by individual-level and area-based measures of socioeconomic status, 2000 to 2002.

Authors:  Steven S Coughlin; Jessica King; Thomas B Richards; Donatus U Ekwueme
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-11       Impact factor: 4.254

4.  The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women.

Authors:  H Minkoff; L Ahdieh; L S Massad; K Anastos; D H Watts; S Melnick; L Muderspach; R Burk; J Palefsky
Journal:  AIDS       Date:  2001-11-09       Impact factor: 4.177

5.  Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.

Authors:  Gary M Clifford; Jerry Polesel; Martin Rickenbach; Luigino Dal Maso; Olivia Keiser; Andreas Kofler; Elisabetta Rapiti; Fabio Levi; Gernot Jundt; Thomas Fisch; Andrea Bordoni; Daniel De Weck; Silvia Franceschi
Journal:  J Natl Cancer Inst       Date:  2005-03-16       Impact factor: 13.506

6.  Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women.

Authors:  Howard D Strickler; Robert D Burk; Melissa Fazzari; Kathryn Anastos; Howard Minkoff; L Stewart Massad; Charles Hall; Melanie Bacon; Alexandra M Levine; D Heather Watts; Michael J Silverberg; Xiaonan Xue; Nicolas F Schlecht; Sandra Melnick; Joel M Palefsky
Journal:  J Natl Cancer Inst       Date:  2005-04-20       Impact factor: 13.506

7.  Early regression of cervical lesions in HIV-seropositive women receiving highly active antiretroviral therapy.

Authors:  I Heard; V Schmitz; D Costagliola; G Orth; M D Kazatchkine
Journal:  AIDS       Date:  1998-08-20       Impact factor: 4.177

8.  Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women.

Authors:  Linda Ahdieh-Grant; Rui Li; Alexandra M Levine; L Stewart Massad; Howard D Strickler; Howard Minkoff; Michael Moxley; Joel Palefsky; Henry Sacks; Robert D Burk; Stephen J Gange
Journal:  J Natl Cancer Inst       Date:  2004-07-21       Impact factor: 13.506

Review 9.  Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis.

Authors:  Andrew E Grulich; Marina T van Leeuwen; Michael O Falster; Claire M Vajdic
Journal:  Lancet       Date:  2007-07-07       Impact factor: 79.321

10.  Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.

Authors:  Paula Schuman; Suzanne E Ohmit; Robert S Klein; Ann Duerr; Susan Cu-Uvin; Denise J Jamieson; Jean Anderson; Keerti V Shah
Journal:  J Infect Dis       Date:  2003-06-17       Impact factor: 5.226
View more
  3 in total

1.  Persistence of oncogenic and non-oncogenic human papillomavirus is associated with human immunodeficiency virus infection in Kenyan women.

Authors:  Yan Tong; Philip Tonui; Aaron Ermel; Omenge Orang'o; Nelson Wong; Maina Titus; Stephen Kiptoo; Kapten Muthoka; Patrick J Loehrer; Darron R Brown
Journal:  SAGE Open Med       Date:  2020-07-28

2.  Integrating Cervical Cancer Screening with HIV Care in Cameroon: Comparative Risk Analysis of Cervical Disease in HIV-Infected Women Receiving Antiretroviral Therapy to Women in the General Population.

Authors:  Cavin Epie Bekolo; Gillian O'Bryan; François Edmond Tchago; Charlette Nangue; Patrick Sylvestre Bekoule; Basile Kollo
Journal:  PLoS One       Date:  2016-02-11       Impact factor: 3.240

3.  Longer duration of anti-retroviral therapy is associated with decreased risk of human papillomaviruses detection in Kenyan women living with HIV.

Authors:  Aaron Ermel; Yan Tong; Phillip Tonui; Omenge Orang'o; Kapten Muthoka; Nelson Wong; Titus Manai; Stephen Kiptoo; Patrick J Loehrer; Darron R Brown
Journal:  Int J STD AIDS       Date:  2021-07-07       Impact factor: 1.359
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.